Cargando…

Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder

INTRODUCTION: Abnormal lipid metabolism in patients with major depressive disorder (MDD) has received increasing attention. The coexistence of MDD and abnormal thyroid function has been intensively studied. Moreover, thyroid function is closely related to lipid metabolism. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jieqiong, Ji, Yunxin, Lang, Xiaoe, Zhang, Xiang-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971224/
https://www.ncbi.nlm.nih.gov/pubmed/36865071
http://dx.doi.org/10.3389/fpsyt.2023.1085105
_version_ 1784898066241814528
author Hu, Jieqiong
Ji, Yunxin
Lang, Xiaoe
Zhang, Xiang-Yang
author_facet Hu, Jieqiong
Ji, Yunxin
Lang, Xiaoe
Zhang, Xiang-Yang
author_sort Hu, Jieqiong
collection PubMed
description INTRODUCTION: Abnormal lipid metabolism in patients with major depressive disorder (MDD) has received increasing attention. The coexistence of MDD and abnormal thyroid function has been intensively studied. Moreover, thyroid function is closely related to lipid metabolism. The aim of this study was to investigate the relationship between thyroid function and abnormal lipid metabolism in young patients with first-episode and drug naïve (FEDN) MDD. METHODS: A total of 1,251 outpatients aged 18–44 years with FEDN MDD were enrolled. Demographic data were collected, and lipid and thyroid function levels were measured, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free tetraiodothyronine (FT4), anti-thyroglobulin antibody (TG-Ab), and anti-thyroid peroxidase antibody (TPO-Ab). The Hamilton Rating Scale for Depression (HAMD), Hamilton Anxiety Rating Scale (HAMA), and Positive and Negative Syndrome Scale (PANSS) positive subscale were also assessed for each patient. RESULTS: Compared with young MDD patients without comorbid lipid metabolism abnormalities, patients with comorbid lipid metabolism abnormalities had higher body mass index (BMI) values, HAMD score, HAMA score, PANSS positive subscale score, TSH levels, TG-Ab levels, and TPO-Ab levels. Binary logistic regression analysis showed that TSH level, HAMD score and BMI were risk factors for abnormal lipid metabolism. TSH levels were an independent risk factor for abnormal lipid metabolism in young MDD patients. Stepwise multiple linear regression showed that both TC and LDL-C levels were positively correlated with TSH levels, HAMD and PANSS positive subscale scores, respectively. HDL-C levels were negatively correlated with TSH levels. TG levels were positively correlated with TSH and TG-Ab levels and HAMD score. DISCUSSION: Our results show that thyroid function parameters, especially TSH levels, are implicated in abnormal lipid metabolism in young patients with FEDN MDD.
format Online
Article
Text
id pubmed-9971224
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99712242023-03-01 Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder Hu, Jieqiong Ji, Yunxin Lang, Xiaoe Zhang, Xiang-Yang Front Psychiatry Psychiatry INTRODUCTION: Abnormal lipid metabolism in patients with major depressive disorder (MDD) has received increasing attention. The coexistence of MDD and abnormal thyroid function has been intensively studied. Moreover, thyroid function is closely related to lipid metabolism. The aim of this study was to investigate the relationship between thyroid function and abnormal lipid metabolism in young patients with first-episode and drug naïve (FEDN) MDD. METHODS: A total of 1,251 outpatients aged 18–44 years with FEDN MDD were enrolled. Demographic data were collected, and lipid and thyroid function levels were measured, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free tetraiodothyronine (FT4), anti-thyroglobulin antibody (TG-Ab), and anti-thyroid peroxidase antibody (TPO-Ab). The Hamilton Rating Scale for Depression (HAMD), Hamilton Anxiety Rating Scale (HAMA), and Positive and Negative Syndrome Scale (PANSS) positive subscale were also assessed for each patient. RESULTS: Compared with young MDD patients without comorbid lipid metabolism abnormalities, patients with comorbid lipid metabolism abnormalities had higher body mass index (BMI) values, HAMD score, HAMA score, PANSS positive subscale score, TSH levels, TG-Ab levels, and TPO-Ab levels. Binary logistic regression analysis showed that TSH level, HAMD score and BMI were risk factors for abnormal lipid metabolism. TSH levels were an independent risk factor for abnormal lipid metabolism in young MDD patients. Stepwise multiple linear regression showed that both TC and LDL-C levels were positively correlated with TSH levels, HAMD and PANSS positive subscale scores, respectively. HDL-C levels were negatively correlated with TSH levels. TG levels were positively correlated with TSH and TG-Ab levels and HAMD score. DISCUSSION: Our results show that thyroid function parameters, especially TSH levels, are implicated in abnormal lipid metabolism in young patients with FEDN MDD. Frontiers Media S.A. 2023-02-14 /pmc/articles/PMC9971224/ /pubmed/36865071 http://dx.doi.org/10.3389/fpsyt.2023.1085105 Text en Copyright © 2023 Hu, Ji, Lang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Hu, Jieqiong
Ji, Yunxin
Lang, Xiaoe
Zhang, Xiang-Yang
Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title_full Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title_fullStr Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title_full_unstemmed Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title_short Association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
title_sort association of thyroid function with abnormal lipid metabolism in young patients with first-episode and drug naïve major depressive disorder
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971224/
https://www.ncbi.nlm.nih.gov/pubmed/36865071
http://dx.doi.org/10.3389/fpsyt.2023.1085105
work_keys_str_mv AT hujieqiong associationofthyroidfunctionwithabnormallipidmetabolisminyoungpatientswithfirstepisodeanddrugnaivemajordepressivedisorder
AT jiyunxin associationofthyroidfunctionwithabnormallipidmetabolisminyoungpatientswithfirstepisodeanddrugnaivemajordepressivedisorder
AT langxiaoe associationofthyroidfunctionwithabnormallipidmetabolisminyoungpatientswithfirstepisodeanddrugnaivemajordepressivedisorder
AT zhangxiangyang associationofthyroidfunctionwithabnormallipidmetabolisminyoungpatientswithfirstepisodeanddrugnaivemajordepressivedisorder